Isolation of human cancer cell growth inhibitory, antimicrobial lateritin from a mixed fungal culture

Planta Medica

Volumn 76, Issue 5, 2010, Pages 500-501

  Pettit, Robin K ^a   Pettit, George R ^a   Xu, Jung Ping ^a   Weber, Christine A ^a   Richert, Linda A ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Anticancer agent; Coculture; Lateritin; Mixed fermentation; Natural product

Indexed keywords

LATERITIN; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANDIDA ALBICANS; COCULTURE; DRUG ISOLATION; FERMENTATION; FUNGUS CULTURE; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CANDIDA ALBICANS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DRUG DISCOVERY; FUNGI; GRAM-POSITIVE BACTERIA; GROWTH INHIBITORS; HUMANS; MORPHOLINES;

CANDIDA ALBICANS; FUNGI; POSIBACTERIA;

EID: 77950240421     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240617     Document Type: Article

References (13)

1. Pettit R K. Mixed fermentation for natural product drug discovery. Appl Microbiol Biotechnol 2009 83 19-25
2. Hasumi K H., Shinohara C, Iwanaga T, Endo A. Lateritin, a new inhibitor of acyl-coA: cholesterol acyltransferase produced by Gibberella lateritium IFO 7188. J Antibiot 1993 46 1782-1787
3. Oh H, Taewan K, Oh G S., Pae H O., Hong K H., Chai K Y., Kwon T O., Chung H T., Lee H S. (3R,6R)-4-methyl-6-(1-methylethyl)-3-phenylmethyl-perhydro-1,4- oxazine-2,5-dione: an apoptosis-inducer from the fruiting bodies of Isaria japonica. Planta Med 2002 68 345-348
4. 21 (PD 156252): examination of its pharmacokinetic and spectral properties. J Med Chem 1997 40 2228-2240
5. Fairlie D P., Abbenante G, March D R. Macrocyclic peptidomimetics- forcing peptides into bioactive conformations. Curr Med Chem 1995 2 654-686
6. Haviv F, Fitzpatrick T D., Swenson R E., Nichols C J., Mort N A., Bush E N., Diaz G, Bammert G, Nguyen A, Rhutasel N S., Nellans H N., Hoffman D J. Effect of N -methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists. J Med Chem 1993 36 363-369
7. Türker R K., Hall M M., Yamamoto M, Sweet C S., Bumpus F M. A new, long-lasting competitive inhibitor of angiotensin. Science 1972 177 1203-1205
8. Hughes A B., Sleebs M M. Total synthesis of bassiatin and its stereoisomers: novel divergent behavior of substrates in Mitsunobu cyclizations. J Org Chem 2005 70 3079-3088
9. Kagamizono T, Nishino E, Matsumoto K, Kawashima A, Kishimoto M, Sakai N, He B M., Chen Z X., Adachi T, Morimoto S, Hanada K. Bassiatin, a new platelet aggregation inhibitor produced by Beauveria bassiana K-717. J Antibiot 1995 48 1407-1412
10. Suffness M, Douros J. Approach to acquisition of new anticancer drugs. Drugs of plant origin. Methods Cancer Res 1979 16 73-126
11. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991 83 757-766
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A4. Wayne NCCLS 1997
13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A. Wayne NCCLS 1997